In non-small cell lung cancer, this invasive pathway occurs in the Nav1.7 subunit through the epidermal growth factor (EGF) - signal-regulated and kinase 1/2 (ERK1/2) pathway (Campbell et al., 2013). This evidence concerns the gene EGF and non-small cell lung carcinoma.